Background: Coronavirus disease (Covid-19) becomes a pandemic worldwide in 2020. Different dermatological manifestations associated with Covid-19 infection like maculopapular, morbilliform, urticarial, vesicular, chilblain-like, petechiae, purpura, and livedoid rashes. Pityriasis rosea (PR) and PR-like eruptions were recently reported to increase in coronavirus cases. Aim: To evaluate and review the literature on PR and PR-like eruption associated with Covid-19 disease. Case Report: A 24-year-old female patient presented with a history of asymptomatic PR-like eruption that started during infection with the Covid-19 virus and resolved spontaneously over 14 weeks without therapy. Conclusion: PR and PR-like eruptions are not uncommon with Covid-19 disease and could be the early manifestation of SARS-CoV-2 virus infection.
References
[1]
Litchman, G., Nair, P.A. and Le, J.K. (2022) Pityriasis Rosea. StatPearls Publishing, Treasure Island.
[2]
Drago, F., Ciccarese, G., Rebora, A., Broccolo, F. and Parodi, A. (2016) Pityriasis Rosea: A Comprehensive Classification. Dermatology (Basel, Switzerland), 232, 431-437. https://doi.org/10.1159/000445375
[3]
Leung, A., Lam, J.M., Leong, K.F. and Hon, K.L. (2021) Pityriasis Rosea: An Updated Review. Current Pediatric Reviews, 17, 201-211. https://doi.org/10.2174/1573396316666200923161330
[4]
Mahajan, K., Relhan, V., Relhan, A.K. and Garg, V.K. (2016) Pityriasis Rosea: An Update on Etiopathogenesis and Management of Difficult Aspects. Indian Journal of Dermatology, 61, 375-384. https://doi.org/10.4103/0019-5154.185699
[5]
VanRavenstein, K. and Edlund, B.J. (2017) Diagnosis and Management of Pityriasis Rosea. The Nurse Practitioner, 42, 8-11. https://doi.org/10.1097/01.NPR.0000511012.21714.66
[6]
Chuh, A., Lee, A., Zawar, V., Sciallis, G. and Kempf, W. (2005) Pityriasis Rosea—An Update. Indian Journal of Dermatology, Venereology, and Leprology, 71, 311-315. https://doi.org/10.4103/0378-6323.16779
[7]
Chhabra, N., Prabha, N., Kulkarni, S. and Ganguly, S. (2018) Pityriasis Rosea: Clinical Profile from Central India. Indian Dermatology Online Journal, 9, 414-417. https://doi.org/10.4103/idoj.IDOJ_12_18
[8]
Amer, A., Fischer, H. and Li, X. (2007) The Natural History of Pityriasis Rosea in Black American Children: How Correct Is the “Classic” Description. Archives of Pediatrics and Adolescent Medicine, 161, 503-506. https://doi.org/10.1001/archpedi.161.5.503
[9]
Zawar, V. (2010) Unilateral Pityriasis Rosea in a Child. Journal of Dermatological Case Reports, 4, 54-56. https://doi.org/10.3315/jdcr.2010.1057
[10]
Min, J.Y. and Jang, Y.J. (2012) Macrolide Therapy in Respiratory Viral Infections. Mediators of Inflammation, 2012, Article ID: 649570. https://doi.org/10.1155/2012/649570
[11]
Poddighe, D. and Aljofan, M. (2020) Clinical Evidence on the Antiviral Properties of Macrolide Antibiotics in the Covid-19 Era and Beyond. Antiviral Chemistry & Chemotherapy, 28, 2040206620961712. https://doi.org/10.1177/2040206620961712
[12]
Centers for Disease Control and Prevention (2021, December 21) Coronavirus Disease 2019 (Covid-19). https://www.cdc.gov/dotw/Covid-19/index.html
[13]
Seque, C.A., Enokihara, M.M., Porro, A.M. and Tomimori, J. (2022) Skin Manifestations Associated with Covid-19. Anais Brasileiros de Dermatologia, 97, 75-88. https://doi.org/10.1016/j.abd.2021.08.002
[14]
Genovese, G., Moltrasio, C., Berti, E. and Marzano, A.V. (2021) Skin Manifestations Associated with Covid-19: Current Knowledge and Future Perspectives. Dermatology (Basel, Switzerland), 237, 1-12. https://doi.org/10.1159/000512932
[15]
Singh, H., Kaur, H., Singh, K. and Sen, C.K. (2021) Cutaneous Manifestations of Covid-19: A Systematic Review. Advances in Wound Care, 10, 51-80. https://doi.org/10.1089/wound.2020.1309
[16]
Veraldi, S., Romagnuolo, M. and Benzecry, V. (2021) Pityriasis Rosea-Like Eruption Revealing Covid-19. The Australasian Journal of Dermatology, 62, e333-e334. https://doi.org/10.1111/ajd.13504
[17]
Merhy, R., Sarkis, A.S. and Stephan, F. (2021) Pityriasis Rosea Is a Leading Manifestation of Covid-19 Infection. Journal of the European Academy of Dermatology and Venereology: JEADV, 35, e246-e247. https://doi.org/10.1111/jdv.17052
[18]
Johansen, M., Chisolm, S.S., Aspey, L.D. and Brahmbhatt, M. (2021) Pityriasis Rosea in Otherwise Asymptomatic Confirmed Covid-19-Positive Patients: A Report of 2 Cases. JAAD Case Reports, 7, 93-94. https://doi.org/10.1016/j.jdcr.2020.10.035
[19]
Martora, F., Picone, V., Fornaro, L., Fabbrocini, G. and Marasca, C. (2022) Can Covid-19 Cause Atypical Forms of Pityriasis Rosea Refractory to Conventional Therapies. Journal of Medical Virology, 94, 1292-1293. https://doi.org/10.1002/jmv.27535
[20]
Öncü, I.N.S., Güler, D., Gürel, G. and Yalçın, G.Ş. (2021) Pityriasis Rosea in a Confirmed Covid-19 Pediatric Patient. Actas Dermo-Sifiliograficas, 112, 864-865. https://doi.org/10.1016/j.ad.2021.05.003
[21]
Martín Enguix, D., Salazar Nievas, M.D.C. and Martín Romero, D.T. (2020) Pityriasis Rosea Gibert Type Rash in an Asymptomatic Patient That Tested Positive for Covid-19. Medicina Clinica (English ed.), 155, 273. https://doi.org/10.1016/j.medcle.2020.05.017
[22]
Ehsani, A.H., Nasimi, M. and Bigdelo, Z. (2020) Pityriasis Rosea as a Cutaneous Manifestation of Covid-19 Infection. Journal of the European Academy of Dermatology and Venereology: JEADV, 34, e436-e437. https://doi.org/10.1111/jdv.16579
[23]
Drago, F., Ciccarese, G., Rebora, A. and Parodi, A. (2021) Human Herpesvirus-6, -7, and Epstein-Barr Virus Reactivation in Pityriasis Rosea during Covid-19. Journal of Medical Virology, 93, 1850-1851. https://doi.org/10.1002/jmv.26549
[24]
Sanchez, A., Sohier, P., Benghanem, S., L’Honneur, A.S., Rozenberg, F., Dupin, N. and Garel, B. (2020) Digitate Papulosquamous Eruption Associated with Severe Acute Respiratory Syndrome Coronavirus 2 Infection. JAMA Dermatology, 156, 819-820. https://doi.org/10.1001/jamadermatol.2020.1704
[25]
Paolino, G., Di Nicola, M.R., Cantisani, C. and Mercuri, S.R. (2021) Pityriasis Rosea Infection in a Covid-19 Patient Successfully Treated with Systemic Steroid and Antihistamine via Telemedicine: Literature Update of a Possible Prodromal Symptom of an Underlying SARS-CoV-2 Infection. Dermatologic Therapy, 34, e14972. https://doi.org/10.1111/dth.14972
[26]
Dursun, R. and Temiz, S.A. (2020) The Clinics of HHV-6 Infection in Covid-19 Pandemic: Pityriasis Rosea and Kawasaki Disease. Dermatologic Therapy, 33, e13730. https://doi.org/10.1111/dth.13730
[27]
Errichetti, E. and Stinco, G. (2016) Dermoscopy in General Dermatology: A Practical Overview. Dermatology and Therapy, 6, 471-507. https://doi.org/10.1007/s13555-016-0141-6
[28]
Elmas, Ö., Kilitçi, A. and Acar, E. (2019) Dermoscopic Profile of Pityriasis Rosea. Dermatologica Sinica, 37, 199-204. https://doi.org/10.4103/ds.ds_14_19
[29]
Galván Casas, C., Català, A., Carretero Hernández, G., et al. (2020) Classification of the Cutaneous Manifestations of Covid-19: A Rapid Prospective Nationwide Consensus Study in Spain with 375 Cases. British Journal of Dermatology, 183, 71-77.
[30]
Su, C.J. and Lee, C.H. (2020) Viral Exanthem in Covid-19, a Clinical Enigma with Biological Significance. The Journal of the European Academy of Dermatology and Venereology, 34, e251-e252. https://doi.org/10.1111/jdv.16469
[31]
Temiz, S.A., Dursun, R., Daye, M. and Ataseven, A. (2020) Evaluation of Dermatology Consultations in the Era of Covid-19. Dermatologic Therapy, 33, e13642. https://doi.org/10.1111/dth.13642
[32]
Estébanez, A., Pérez-Santiago, L., Silva, E., Guillen-Climent, S., GarcíaVázquez, A. and Ramón, M.D. (2020) Cutaneous Manifestations in Covid-19: A New Contribution. Journal of the European Academy of Dermatology and Venereology, 34, e250-e251. https://doi.org/10.1111/jdv.16474
[33]
Recalcati, S. (2020) Cutaneous Manifestations in Covid-19: A First Perspective. Journal of the European Academy of Dermatology and Venereology: JEADV, 34, e212-e213. https://doi.org/10.1111/jdv.16387
[34]
Drago, F., Broccolo, F. and Rebora, A. (2009) Pityriasis Rosea: An Update with a Critical Appraisal of Its Possible Herpesviral Etiology. Journal of the American Academy of Dermatology, 61, 303-318. https://doi.org/10.1016/j.jaad.2008.07.045
[35]
Broccolo, F., Drago, F., Careddu, A.M., Foglieni, C., Turbino, L., Cocuzza, C.E., Gelmetti, C., Lusso, P., Rebora, A.E. and Malnati, M.S. (2005) Additional Evidence Is That Pityriasis Rosea Is Associated with the Reactivation of Human Herpesvirus-6 and -7. The Journal of Investigative Dermatology, 124, 1234-1240. https://doi.org/10.1111/j.0022-202X.2005.23719.x
[36]
Drago, F., Ranieri, E., Malaguti, F., Battifoglio, M.L., Losi, E. and Rebora, A. (1997) Human Herpesvirus 7 in Patients with Pityriasis Rosea. Electron Microscopy Investigations and Polymerase Chain Reaction in Mononuclear Cells, Plasma, and Skin. Dermatology (Basel, Switzerland), 195, 374-378. https://doi.org/10.1159/000245991
[37]
Watanabe, T., Kawamura, T., Jacob, S.E., Aquilino, E.A., Orenstein, J.M., Black, J.B. and Blauvelt, A. (2002) Pityriasis Rosea Is Associated with Systemic Active Infection with both Human Herpesvirus-7 and Human Herpesvirus-6. The Journal of Investigative Dermatology, 119, 793-797. https://doi.org/10.1046/j.1523-1747.2002.00200.x
[38]
Mukai, T., Yamamoto, T., Kondo, T., Kondo, K., Okuno, T., Kosuge, H. and Yamanishi, K. (1994) Molecular Epidemiological Studies of Human Herpesvirus 6 in Families. Journal of Medical Virology, 42, 224-227. https://doi.org/10.1002/jmv.1890420303
[39]
Drago, F. and Rebora, A. (2003) Viral Reactivation and Skin Eruptions. Dermatology (Basel, Switzerland), 207, 1-2. https://doi.org/10.1159/000070931
[40]
Katsafanas, G.C., Schirmer, E.C., Wyatt, L.S. and Frenkel, N. (1996) In Vitro Activation of Human Herpesviruses 6 and 7 from Latency. Proceedings of the National Academy of Sciences of the United States of America, 93, 9788-9792. https://doi.org/10.1073/pnas.93.18.9788
[41]
Gianotti, R., Veraldi, S., Recalcati, S., Cusini, M., Ghislanzoni, M., Boggio, F. and Fox, L.P. (2020) Cutaneous Clinico-Pathological Findings in Three Covid-19-Positive Patients Observed in the Metropolitan Area of Milan, Italy. Acta Dermato-Venereologica, 100, adv00124. https://doi.org/10.2340/00015555-3490
